Rejuvenate Biomed

Vrunstraat 153

3550 Heusden-Zolder

BE

Rejuvenate Biomed

Foundation date

02/10/2017

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

Rejuvenate Biomed is a Belgian based biomedical company engaged in developing prescription drugs in healthy ageing.
By applying the progress made in geroscience (biology of aging) we identify and develop (up to POC) safe and well tolerated drugs that balance core biological processes associated with age-related functional decline.

Upcoming events

Latest news

  • HERAN Partners co-leads the GBP 6,5m financing round of Hypervision Surgical to support the further development and commercial roll-out of their Hyperspectral Imaging platform

    Tuesday June 6th 2023

  • ANeuroTech receives IND approval from the FDA for pivotal Phase IIIB trial of adjunctive anti-depression drug, ANT-01

    Monday June 5th 2023

  • Biotalys continues to demonstrate strength of first biocontrol in latest global field trials

    Friday June 2nd 2023